Results 141 to 150 of about 3,554 (229)

Targeting Growth Hormone Receptor to Overcome Therapy Resistance in Non-Small Cell Lung Cancer. [PDF]

Int J Mol Sci
Ahmad A, Basu R, Fyffe C, Geiger R, Walsh C, Minto D, Brenya E, Alur AV, Neggers SJCMM, Kopchick JJ.   +9 more
europepmc   +1 more source

MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar [PDF]

, 2020
Sabrina Chiloiro, Antonella Giampietro, Antonio Bianchi, Felicia Visconti, Anna Maria Formenti, Fleseriu Maya Cara, Alfredo Pontecorvi, Maria Fleseriu, Andrea Giustina, Laura De Marinis   +9 more
openalex   +1 more source

Acromegaly treatment and bone: a bidirectional relationship. [PDF]

Pituitary
Chiloiro S, Palumbo C, Giampietro A, De Marinis L, Bianchi A, Giustina A, Pontecorvi A.   +6 more
europepmc   +1 more source

Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant [PDF]

, 2008
Sebastian Neggers, Maarten O. van Aken, Wouter W. de Herder, Richard A. Feelders, J. A. M. J. L. Janssen, Xavier Badı́a, Susan M. Webb, A. J. van der Lely   +7 more
openalex   +1 more source

Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy [PDF]

, 2007
Donghua Yin, Franzanne Vreeland, Larry J. Schaaf, Robert Millham, Barbara A. Duncan, Amarnath Sharma   +5 more
openalex   +1 more source

Cabergoline monotherapy in GH- and PRL-cosecreting pituitary adenomas. [PDF]

Endocr Oncol
McNeil JM, Candy NC, Jukes AK, De Sousa SMC.   +3 more
europepmc   +1 more source

Plasma Agouti-Related Protein Levels in Acromegaly and Effects of Surgical or Pegvisomant Therapy [PDF]

, 2019
Pamela U. Freda, Carlos Reyes-Vidal, Zhezhen Jin, M. L. Pugh, Sunil K. Panigrahi, Jeffrey N. Bruce, Sharon L. Wardlaw   +6 more
openalex   +1 more source

Real-world burden of disease, treatment, and healthcare resource utilization in acromegaly: a quantitative survey of patient experiences. [PDF]

J Patient Rep Outcomes
Koobatian M, Sisco J, Okeyo JC, Krasner A, Quock TP.   +4 more
europepmc   +1 more source

Combined treatment with octreotide LAR and pegvisomant in patients with gigantism - acromegaly: clinical evaluation and genetic screening [PDF]

, 2016
Liliya Rostomyan, Ruth Mangupli, Emilie Castermans, Jean-Hubert Caberg, Paul Camperos, Elvia Cuauro, Vincent Bours, Adrian Daly, Albert Beckers   +8 more
openalex   +1 more source

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

, 2019
Aart Jan van der Lely
openalex   +1 more source